Pre-Market Momentum Builds For Teva On Positive FDA News
Fahim Awan
May 5, 2025
Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares were increasing notably after a major regulatory development. Its shares jumped 5.62% in pre-market trading to $17.10. The